Molnupiravir is a relatively novel antiviral drug that has generated significant excitement as a possible treatment for COVID-19. The drug works by interfering with the ability of the virus to replicate within the body, thereby reducing the severity and duration of infection. Clinical trials have shown that Molnupiravir can be successful in reducin